他汀类药物在心血管疾病中激活血红素加氧酶-1的作用

Title:The Role of Statins in the Activation of Heme Oxygenase-1 in Cardiovascular Diseases

Volume: 18 Issue: 6

关键词: 腹主动脉瘤，抗氧化剂，动脉粥样硬化，心脏病，心血管疾病，血红素加氧酶-1，氧化应激，他汀类药物。

摘要: Cardiovascular diseases (CVD) are associated with the dysfunction of endothelium that regulates the contractile state of vascular walls and cellular composition. Recent large clinical trials indicated that lipid-modifying interventions decrease the risk of CVD in patients with hypercholesterolemia and in those with relatively normal levels of LDL cholesterol. They also highlighted lipid-independent role of well-established lipid-lowering drugs- statins- which inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and are used in the treatment of hypercholesterolemia and reduction of atherosclerosis. Novel therapeutic approaches of statins include their influence on heme oxygenase 1 (HO-1) and HO-1 related signaling pathways such as activator protein (AP)-1, protein kinase G (PKG), extracellular matrix-regulated kinase (ERK), p38 MAPK or NFκB in vascular wall cells. This review aimed to describe the molecular mechanisms involved in the induction of HO-1 under different statins in the most common CVD.

Cite this article as:

The Role of Statins in the Activation of Heme Oxygenase-1 in Cardiovascular Diseases, Current Drug Targets 2017; 18 (6) . https://dx.doi.org/10.2174/1389450117666160401123600